Zacks Investment Research on MSN
Puma Biotechnology stock rises 19% in 3 months: Here's why
Shares of Puma Biotechnology PBYI have witnessed a sharp increase in the past three months, driven by investor optimism ...
Biogen Inc. (BIIB) is a leading biotechnology company focused on discovering, developing, and delivering therapies for ...
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry ...
If you’re looking to diversify outside of AI, especially as AI investors look to trim their winners to save up for that mega-cap AI IPO boom on the horizon, with SpaceX leading the way, the biotech ...
In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...
Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust clinical pipeline.
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?
Kyverna Therapeutics operates as a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases. Its lead product candidate, KYV-101, is a CAR ...
The largest-ever new stock sale for a venture-backed biotech company extends a streak of large IPOs in 2026 that’s now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results